Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.

Molecular carcinogenesis - 1 Feb 2001

Honchel R, Rosenzweig B A, Thompson K L, Blanchard K T, Furst S M, Stoll R E, Sistare F D

Abstract excerpt

The Tg.AC transgenic mouse carries the v-Ha-ras oncogene under the control of the zeta-globin promoter and is currently being used in a short-term carcinogenesis assay for safety testing of pharmaceuticals. A subset of hemizygous Tg.AC mice was found to be nonresponsive to the tumor promoter 12-O...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Blotting, Southern
Share to Genes, ras
Share to Globins

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Nucleic Acid Conformation

Share to Repetitive Sequences, Nucleic Acid

Share to Sequence Homology, Nucleic Acid

Share to Single-Strand Specific DNA and RNA Endonucleases

Share to Transgenes

Source

Identifiers

PMID: 11241757

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-11241757-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Loss of palindromic symmetry in Tg.AC mice with a nonresponder phenotype.PMID 11241757Read ↗

Loss of critical palindromic transgene promoter sequence in chemically induced Tg.AC mouse skin papillomas expressing transgene-derived mRNA.Semantic proximity Read ↗

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. II. A genotypic marker that predicts tumorigenic responsiveness.Semantic proximity Read ↗

An evaluation of the hemizygous transgenic Tg.AC mouse for carcinogenicity testing of pharmaceuticals. I. Evidence for a confounding nonresponder phenotype.Semantic proximity Read ↗

Genetic interaction between the unstable v-Ha-RAS transgene (Tg.AC) and the murine Werner syndrome gene: transgene instability and tumorigenesis.Semantic proximity Read ↗

Chemiluminescence-based method for genotyping Tg.AC responder mice.Semantic proximity Read ↗

Decreases in phorbol ester-induced papilloma development in v-Ha-ras transgenic TG.AC mice during reduced gene dosage of bcl-2.Semantic proximity Read ↗

Evaluation of the Tg.AC transgenic mouse assay for testing the human carcinogenic potential of pharmaceuticals--practical pointers, mechanistic clues, and new questions.Semantic proximity Read ↗

Photocarcinogenesis and susceptibility to UV radiation in the v-Ha-ras transgenic Tg.AC mouse.Semantic proximity Read ↗

Tumor spectrum in the p53 heterozygous zeta globin-promoted Tg.AC (v-Ha-ras) bitransgenic mouse model.Semantic proximity Read ↗

PCR method for genotyping and zygosity-testing of RasH2 transgenic mice.Semantic proximity Read ↗

TGF alpha is dispensable for skin tumorigenesis in Tg.AC mice.Semantic proximity Read ↗

Alterations in protein kinase C isozymes alpha and beta 2 in activated Ha-ras containing papillomas in the absence of an increase in diacylglycerol.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.